Simris Group AB (PUBL) (STO:SIMRIS.B)
Sweden · Delayed Price · Currency is SEK 0.0952
-0.0093 (-8.90%)
Aug 13, 2026, 4:58 PM CET
Simris Group AB (PUBL) Market Cap
Simris Group AB (PUBL) has a market cap or net worth of 128.5 million as of August 13, 2026. Its market cap has increased by 28.47% in one year.
Market Cap
128.50M
Enterprise Value
120.51M
Revenue
3.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
ChartMarket Cap Chart
Since April 22, 2016, Simris Group AB (PUBL)'s market cap has increased from 122.27M to 128.50M, an increase of 5.09%. That is a compound annual growth rate of 0.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 128.50M | 380.26% |
| Dec 30, 2025 | 26.76M | 0.88% |
| Dec 30, 2024 | 26.52M | -66.13% |
| Dec 29, 2023 | 78.32M | 72.71% |
| Dec 30, 2022 | 45.35M | -21.98% |
| Dec 30, 2021 | 58.12M | 3.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xbrane Biopharma AB | 209.14M |
| Alzinova AB | 206.69M |
| Initiator Pharma | 177.29M |
| Abera Bioscience AB | 168.91M |
| Elicera Therapeutics AB | 166.51M |
| Biovica International AB | 160.55M |
| Diamyd Medical AB | 158.70M |
| Xintela AB | 156.32M |